Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Publication year range
1.
Mem Inst Oswaldo Cruz ; 99(2): 179-84, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15250472

ABSTRACT

The evaluation of new antimalarial agents using older methods of monitoring sensitivity to antimalarial drugs are laborious and poorly suited to discriminate stage-specific activity. We used flow cytometry to study the effect of established antimalarial compounds, cysteine protease inhibitors, and a quinolone against asexual stages of Plasmodium falciparum. Cultured P. falciparum parasites were treated for 48 h with different drug concentrations and the parasitemia was determined by flow cytometry methods after DNA staining with propidium iodide. P. falciparum erythrocytic life cycle stages were readily distinguished by flow cytometry. Activities of established and new antimalarial compounds measured by flow cytometry were equivalent to results obtained with microscopy and metabolite uptake assays. The antimalarial activity of all compounds was higher against P. falciparum trophozoite stages. Advantages of flow cytometry analysis over traditional assays included higher throughput for data collection, insight into the stage-specificity of antimalarial activity avoiding use of radioactive isotopes.


Subject(s)
Antimalarials/pharmacology , Cysteine Proteinase Inhibitors/pharmacology , Hypoxanthine/metabolism , Plasmodium falciparum/drug effects , Quinolones/pharmacology , Animals , Drug Evaluation, Preclinical , Flow Cytometry , Lethal Dose 50 , Parasitic Sensitivity Tests , Plasmodium falciparum/enzymology , Plasmodium falciparum/growth & development
2.
Mem. Inst. Oswaldo Cruz ; 99(2): 179-184, Mar. 2004. ilus, tab, graf
Article in English | LILACS | ID: lil-360972

ABSTRACT

The evaluation of new antimalarial agents using older methods of monitoring sensitivity to antimalarial drugs are laborious and poorly suited to discriminate stage-specific activity. We used flow cytometry to study the effect of established antimalarial compounds, cysteine protease inhibitors, and a quinolone against asexual stages of Plasmodium falciparum. Cultured P. falciparum parasites were treated for 48 h with different drug concentrations and the parasitemia was determined by flow cytometry methods after DNA staining with propidium iodide. P. falciparum erythrocytic life cycle stages were readily distinguished by flow cytometry. Activities of established and new antimalarial compounds measured by flow cytometry were equivalent to results obtained with microscopy and metabolite uptake assays. The antimalarial activity of all compounds was higher against P. falciparum trophozoite stages. Advantages of flow cytometry analysis over traditional assays included higher throughput for data collection, insight into the stage-specificity of antimalarial activity avoiding use of radioactive isotopes.


Subject(s)
Animals , Antimalarials , Cysteine Proteinase Inhibitors , Hypoxanthine , Plasmodium falciparum , Quinolones , Flow Cytometry , Lethal Dose 50 , Plasmodium falciparum
3.
Rev. Fac. Cienc. Vet ; 44(2): 131-144, jul.-dic. 2003. ilus
Article in Spanish | LILACS | ID: lil-490679

ABSTRACT

Este estudio evaluó la presencia de Trypanosoma evansi y Trypanosoma vivax en búfalos de agua (Bubalus bubalis) y chigüires (Hydrochoerus hydrochaeris) de tres estados de Venezuela por técnicas parasitológicas y moleculares (frotis teñido: FT; microcentrifugación capilar: TMC; reacción en cadena de la Polimerasa: PCR), estableciéndose el porcentaje de infecciones activas. En 316 muestras sanguíneas de búfalos las tasas de detección para FT, TMC y PCR fueron de 20 (6,33 por ciento), 36 (11,39 por ciento) y 60 (18,98 por ciento),respectivamente. Por PCR se caracterizó a T. vivax como la especie responsable de todas las infecciones, no detectándose presencia de T. evansi. En 186 muestras de chigüires FT y TMC identificaron positividad en 36 (19,35 por ciento) y 71 (38,17 por ciento) de estas, respectivamente, con altas parasitemias; en 27 de estas se observaron tripanosomas del Subgénero Megatrypanum. Por PCR se caracterizaron como T. evansi 51 muestras de chigüires, seis con resultados TMC-negativo. No se detectó T. vivax en chigüires. Un análisis de t-student estableció diferencias (p<0.05) entre los valores de hematocrito (Ht) de búfalos positivos y negativos a tripanosomas; mientras que por análisis de varianza se detectó efecto (p< 0.05) del grado de parasitemia sobre el Ht. No hubo ningún efecto (p>0.05) al realizar los mismos análisis para las muestras de chigüires.


Subject(s)
Animals , Buffaloes , Polymerase Chain Reaction , Trypanosoma , Trypanosoma vivax , Trypanosomiasis , Parasitology , Venezuela , Veterinary Medicine
4.
Am J Trop Med Hyg ; 67(4): 400-5, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12452494

ABSTRACT

The state of Bolivar in Venezuela experiences episodic outbreaks of multidrug-resistant Plasmodium falciparum malaria. We obtained P. falciparum-infected blood samples in Bolivar in 1998-2000, and performed molecular assays for mutations conferring resistance to the antifolate combination of sulfadoxine-pyrimethamine (SP) and to chloroquine. All infections carried the dihydrofolate reductase (dhfr) S108A and N51I mutations, and 45% of the infections had the dhfr C50R mutation, which has been implicated in mid-level resistance to SP. Two dihydropteroate synthase (dhps) mutations also involved in SP resistance, A581G and K540E, were detected in 90% and 67% of the samples, respectively. The dhfr 1164L mutation, which confers high-level resistance, was not identified. The P. falciparum chloroquine resistance transporter (pfcrt) K76T mutation, which is critical for chloroquine resistance, was found in 167 of 168 infections. Six dhfr/dhps allelotypes and four pfcrt-resistant alleles were observed. Their interrelationships suggest a semi-clonal propagation of P. falciparum malaria in Bolivar, and an invasion of multi-resistant pathogens from Brazil. Despite national restrictions on the use of SP and chloroquine, genotypic resistance to these therapies remains widespread in Bolivar.


Subject(s)
Malaria, Falciparum/parasitology , Plasmodium falciparum/drug effects , Alleles , Animals , Dihydropteroate Synthase/genetics , Drug Resistance/genetics , Humans , Malaria, Falciparum/epidemiology , Membrane Proteins/genetics , Membrane Transport Proteins , Plasmodium falciparum/genetics , Protozoan Proteins , Tetrahydrofolate Dehydrogenase/genetics , Venezuela/epidemiology
5.
J Infect Dis ; 186(7): 999-1006, 2002 Oct 01.
Article in English | MEDLINE | ID: mdl-12232841

ABSTRACT

Multidrug resistance is a major obstacle to the control of Plasmodium falciparum malaria, and its origins and modes of dissemination are imperfectly understood. In this study, haplotyping and microsatellite analysis of malaria from 5 regions of the South American Amazon support the conclusion that the parasite mutations conferring mid- and high-level resistance to the antifolate combination sulfadoxine-pyrimethamine have a common origin. Parasites harboring these mutations are also found to share drug-resistance alleles that confer a unique chloroquine resistance phenotype and to be similar at loci not linked to drug resistance, although not genetically identical. Since the 1980s, multidrug-resistant P. falciparum has spread in a north-northwest manner across the continent, from an origin likely in the lower Amazon. This study highlights the importance of continent-wide malaria-control policies and suggests that the containment of resistance to the next generation of therapies may be feasible.


Subject(s)
Antimalarials/pharmacology , Malaria, Falciparum/parasitology , Plasmodium falciparum/drug effects , Alleles , Amino Acid Sequence , Animals , Chloroquine/pharmacology , Cloning, Molecular , Drug Resistance, Multiple/genetics , Folic Acid Antagonists/pharmacology , Haplotypes , Humans , Malaria, Falciparum/epidemiology , Microsatellite Repeats , Molecular Sequence Data , Multienzyme Complexes/genetics , Mutation , Plasmodium falciparum/enzymology , Plasmodium falciparum/genetics , Pyrimethamine/pharmacology , South America/epidemiology , Sulfadoxine/pharmacology , Tetrahydrofolate Dehydrogenase/genetics , Thymidylate Synthase/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...